4 research outputs found
Demographic and clinical characteristics of the patients at study entry.
<p>Demographic and clinical characteristics of the patients at study entry.</p
Subgroup analysis of the Kaplan-Meier estimate of the time from remission to first relapse or death (during the planned 24 month-follow-up) in the cyclophosphamide (CYC) and methotrexate (MTX) groups.
<p>The <i>upper panel</i> shows the analysis in patients with GPA or MPA (granulomatosis with polyangiitis or microscopic polyangiitis) while the <i>lower panel</i> shows the analysis in patients with EGPA (eosinophilic granulomatosis with polyangiitis).</p
Relapse frequencies during the planned 24-month follow-up period.
<p>Relapse frequencies during the planned 24-month follow-up period.</p
Adverse events during the planned 24-month follow-up period.
<p>Adverse events during the planned 24-month follow-up period.</p